Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma

World J Urol. 2024 Mar 26;42(1):192. doi: 10.1007/s00345-024-04808-6.

Abstract

Purpose: The diagnostic accuracy of computed tomography urography for upper tract urothelial carcinoma is high; however, difficulties are associated with precisely assessing the T stage. Preoperative tumor staging has an impact on treatment options for upper tract urothelial carcinoma. We herein attempted to identify preoperative factors that predict pathological tumor up-staging, which will facilitate the selection of treatment strategies.

Materials and methods: We retrospectively identified 148 patients with upper tract urothelial carcinoma who underwent computed tomography urography preoperatively followed by radical nephroureterectomy without preoperative chemotherapy at our institution between 2000 and 2021. Preoperative factors associated with cT2 or lower to pT3 up-staging were examined using a multivariate logistic regression analysis.

Results: Ninety out of 148 patients were diagnosed with cT2 or lower, and 22 (24%) were up-staged to pT3. A multivariate analysis identified a positive voided urine cytology (HR 4.69, p = 0.023) and tumor length ≥ 3 cm (HR 6.33, p = 0.003) as independent predictors of pathological tumor up-staging.

Conclusions: Patients diagnosed with cT2 or lower, but with preoperative positive voided urine cytology and/or tumor diameter ≥ 3 cm need to be considered for treatment as cT3.

Keywords: Cancer staging; Nephroureterectomy; Tumor length; Up-staging; Urine cytology; Urothelial carcinoma.

MeSH terms

  • Carcinoma, Transitional Cell* / pathology
  • Humans
  • Neoplasm Staging
  • Nephroureterectomy
  • Retrospective Studies
  • Ureteral Neoplasms* / surgery
  • Urinary Bladder Neoplasms* / pathology